Condition 101 About Chromophobe Renal Cell Carcinoma

What is the definition of Chromophobe Renal Cell Carcinoma?

Chromophobe renal cell carcinoma is a rare subtype of the most common form of kidney cancer called renal cell carcinoma (RCC). This type of cancer forms in the cells lining the small tubules in the kidney. These tubules help filter waste from the blood, making urine. Chromophobe RCC accounts for about 5% of all RCC cases, and it is frequently diagnosed between ages 40 and 50. It is typically diagnosed in stage I or stage II, and has an overall better prognosis than other types of RCC. Treatment generally involves surgery.

What are the alternative names for Chromophobe Renal Cell Carcinoma?

  • CRCC
  • ChRCC

Latest Advances On Chromophobe Renal Cell Carcinoma

  • Condition: Metastatic Renal Cell Carcinoma
  • Journal: Anticancer research
  • Treatment Used: Hypo-fractionated High-dose Stereotactic Radiotherapy
  • Number of Patients: 28
  • Published —
In this study, researchers evaluated the outcomes of adding hypo-fractionated high-dose stereotactic radiotherapy to treatment for oligo-progressive metastatic renal cell carcinoma.
  • Condition: Desmoid Tumor Initially Diagnosed as Metastasis from Renal Cell Carcinoma
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Tumor Resection
  • Number of Patients: 1
  • Published —
This case report describes a 64-year-old man diagnosed with a desmoid tumor that was initially diagnosed as metastasis from renal cell carcinoma treated with tumor resection.

Clinical Trials For Chromophobe Renal Cell Carcinoma

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 21
  • Start Date: June 1, 2021
A Phase 2 Study of Pamiparib (BGB-290) Plus Temozolomide for Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 90
  • Start Date: March 1, 2021
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma.